Christina Curran, PA
Physician Assistant · Tamarac, FLNPI 1952333577
Payments from drug & device makers
Across 149 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$670
- AbbVie$505
- Sun Pharmaceutical Industries Inc.$331
- Novartis$313
- Sanofi$297
- UCB, Inc.$187
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,06092%
- Education$2518%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $670 |
| AbbVie | 26 | $505 |
| Sun Pharmaceutical Industries Inc. | 12 | $331 |
| Novartis | 15 | $313 |
| Sanofi | 11 | $297 |
| UCB, Inc. | 8 | $187 |
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| Boehringer Ingelheim | 5 | $138 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $133 |
| Pfizer | 5 | $120 |
| Incyte Corporation | 5 | $105 |
| Lilly USA, LLC | 4 | $88 |
| LEO Pharma Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Dermavant Sciences, Inc. | 2 | $50 |
| Amgen | 1 | $24 |
| Biofrontera Inc. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $20 |
How this compares
$3,311 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 65 | $2,830 |
| Ketoconazole | 72 | $998 |
| Clindamycin Phosphate | 24 | $763 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $435 |
| Triamcinolone Acetonide | 41 | $432 |
| Ammonium Lactate | 17 | $355 |
| Doxycycline Hyclate | 19 | $270 |
| Mupirocin | 34 | $247 |
| Methylprednisolone | 11 | $63 |
| Prednisone | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Tamarac
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.